JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quon, A.
Right arrow Articles by Kaplan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quon, A.
Right arrow Articles by Kaplan, M. J.
Journal of Nuclear Medicine Vol. 48 No. 1 (Suppl) 58S-67S
© 2007 by Society of Nuclear Medicine

Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma

Andrew Quon1, Nancy J. Fischbein2, I. Ross McDougall1, Quynh-Thu Le3, Billy W. Loo, Jr.3, Harlan Pinto4 and Michael J. Kaplan5

1 Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California; 2 Division of Neuroradiology, Department of Radiology, Stanford University Medical Center, Stanford, California; 3 Department of Radiation Oncology, Stanford University Medical Center, Stanford, California; 4 Division of Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, California; and 5 Department of Otolaryngology and Head and Neck Surgery, Stanford University Medical Center, Stanford, California

Correspondence: For correspondence contact: Andrew Quon, MD, Division of Nuclear Medicine, Department of Radiology, 300 Pasteur Dr., Stanford, CA 94305. E-mail: aquon{at}stanford.edu

18F-FDG PET/CT has rapidly become a widely used imaging modality for evaluating a variety of malignancies, including squamous cell carcinoma of the head and neck and thyroid cancer. Using both published data and the multidisciplinary experience at our institution, we provide a practical set of guidelines and algorithms for the use of 18F-FDG PET/CT in the evaluation and management of head and neck cancer and thyroid cancer.

Key Words: 18F-FDG • PET/CT • head and neck carcinoma • thyroid carcinoma

COPYRIGHT © 2006 by the Society of Nuclear Medicine, Inc.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
J.M. Debnam, A.S. Garden, and L.E. Ginsberg
Benign Ulceration as a Manifestation of Soft Tissue Radiation Necrosis: Imaging Findings
AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 558 - 562.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Czernin and H. R. Schelbert
Introduction
J. Nucl. Med., January 1, 2007; 48(1_suppl): 2S - 3S.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.